arrow_back Back to App

Drug Security: Mapping Supply Chains and Risk Assessment

This act aims to ensure Americans always have access to essential medicines, especially during crises. The government will track the origin of drugs and their ingredients to prevent shortages and protect public health and national security. This means greater assurance that critical medicines will be available when needed.
Key points
The government will create and regularly update a list of essential medicines crucial for national health and security.
A risk assessment of these medicine supply chains will be conducted to identify vulnerabilities, especially those related to foreign suppliers.
A monitoring system for drug supply chains will be established, using data analytics to quickly detect potential problems and shortages.
The Department of Defense will report on drugs purchased from China, increasing transparency and security of military supplies.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_1784
Sponsor: Sen. Peters, Gary C. [D-MI]
Process start date: 2025-05-15
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

MAPS Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_1784.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-05-15.

What are the main provisions?

Key points include:

  • The government will create and regularly update a list of essential medicines crucial for national health and security.
  • A risk assessment of these medicine supply chains will be conducted to identify vulnerabilities, especially those related to foreign suppliers.
  • A monitoring system for drug supply chains will be established, using data analytics to quickly detect potential problems and shortages.
  • The Department of Defense will report on drugs purchased from China, increasing transparency and security of military supplies.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Peters, Gary C. [D-MI].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Security